Barely Significant
← all excerpts

Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).

Cancer Chemother Pharmacol · 2018 · PMC5754396 · PMID 29094178

Europe PMCDOI
2
hedged sentences
0.1020
closest p · 2.0× alpha
0.1020
boldest claim

The sentences

did not reach statistical significancep = 0.102not close (p > 0.1)
The DFS was slightly worse in the UFT + PSK arm than in the surgery-alone arm, but the difference did not reach statistical significance (log rank p = 0.102).

also in 111,027 other papers

borderline significantno p-value reported
A randomized, double-blind trial as well as a meta-analysis of those trials for resectable gastric cancers showed that PSK provided borderline significant benefits in improving the disease-free survival (DFS) and OS [ 9 , 10 ].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.